FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108412008: Rizatriptan benzoate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
326408015 Rizatriptan benzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600461015 Rizatriptan benzoate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
326408015 Rizatriptan benzoate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
326408015 Rizatriptan benzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
600461015 Rizatriptan benzoate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
600461015 Rizatriptan benzoate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
43201000188119 rizatriptan benzoate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838591000172117 benzoate de rizatriptan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
43201000188119 rizatriptan benzoate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838591000172117 benzoate de rizatriptan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan benzoate Is a Product containing rizatriptan (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Is a Substance with serotonin 5-hydroxytryptamine-1 receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Is a Rizatriptan product false Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Has disposition Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Is modification of (attribute) Rizatriptan product true Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Is a Triazole derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan benzoate Is a Substance with triazole structure (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Rizatriptan 5mg wafer The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan (as rizatriptan benzoate) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan 10mg wafer (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1
Rizatriptan (as rizatriptan benzoate) 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Rizatriptan 10mg conventional release oral lyophilisate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1
Rizatriptan (as rizatriptan benzoate) 10 mg oral tablet Has precise active ingredient True Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1
Rizatriptan (as rizatriptan benzoate) 10 mg oral lyophilisate Has precise active ingredient True Rizatriptan benzoate Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start